pentaerythrityl tetranitrate
Trade name: Pentalong
Small moleculeexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Oct 1, 2002 (NCT00168519)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pentalong
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03669185 | Phase 3 | Jul 26, 2017 | Friedrich Schiller University |
| NCT00168519 | N/A | Oct 1, 2002 | Monash University, National Health and Medical Research Council, Australia, Roche |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Friedrich Schiller University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Monash University | Academic/Hospital | 1 | 1 | 1 | 2002 |
| National Health and Medical Research Council, Australia | Government | 1 | 0 | 1 | 2002 |
| Roche | For profit | 1 | 0 | 1 | 2002 |
4 organizations
Page 1 / 1